Find a clinical trial
A clinical trial is a research study that people can join. Some test a new treatment. Some test a new way to use a treatment we already have. Joining one is always your choice.
Talk to your care team before you contact a trial. They know your history and can tell you whether a trial is worth your time. Nothing on this page is medical advice, and we are not part of any trial.
Trials near you
Enter your ZIP code to see open trials with a site within 50 miles. We use your ZIP only to run that search. We do not store it.
Browse trials
Showing 294 trials. Trials we know are closed are left out. This list is the brain tumor trials we track, not every trial on ClinicalTrials.gov. The search above looks at all of them.
-
Focused radiation after surgery for grade II or returning grade I meningioma
This trial is testing a short, targeted form of radiation given after meningioma surgery.
-
Testing digoxin for medulloblastoma that came back in kids and young adults
This study is testing a drug called digoxin in young people whose medulloblastoma came back.
-
Testing three drugs together for lung cancer that spread to the brain
This study tests three cancer drugs given together after lung cancer spreads to the brain.
-
Adding the drug triapine to radiation for glioblastoma or astrocytoma that has come back
This study tests giving a drug called triapine along with radiation for a brain tumor that has come back.
-
Two drugs tested with radiation for a newly found high-grade glioma
This trial is testing whether two drugs are safe to give before and during radiation.
-
Testing whether pesticide exposure affects glioblastoma treatment
This study looks at whether past pesticide exposure changes how a brain tumor responds to treatment.
-
Testing tarlatamab before and after surgery for high-grade glioma that came back
This study tests a drug called tarlatamab in people having surgery for a brain tumor that came back.
-
Project: Every Child for Younger Patients With Cancer
-
Dabrafenib and/or Trametinib Rollover Study
-
Testing a treatment plan for children and young adults with NGGCT brain tumors
This trial tests how to match chemotherapy and radiation to how well a tumor responds to early treatment.
-
Testing the drug selinexor with radiation for children and young adults with newly diagnosed DIPG or high-grade glioma
This trial is testing whether adding a drug called selinexor to standard radiation can help shrink these brain tumors.
-
Testing Sodium Thiosulfate to Protect Hearing During Medulloblastoma Treatment
This trial is testing whether an added drug can lower hearing loss from medulloblastoma treatment.
-
A study of TY-9591 for lung cancer that has spread to the brain
This study tests a drug called TY-9591 in people whose lung cancer has spread to the brain.
-
A drug switched on by sound waves for glioblastoma that came back or is growing
This study tests a drug that is turned on by focused sound waves aimed at the tumor.
-
Focused radiation before brain surgery, or after it, for cancer that has spread to the brain
This study compares giving focused radiation before brain surgery with giving it after.
-
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
-
Testing changed immune cells for glioblastoma that has come back
This trial tests changed immune cells in people whose glioblastoma has come back.
-
Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
-
Testing NST-628 in adults with grade 4 glioma that came back
This study tests a drug called NST-628 in adults whose grade 4 glioma has returned.
-
Radiation After Surgery or Close Watching for Low-Risk Meningioma
This trial tests whether radiation after surgery helps more than close watching.
Trial information comes from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. We copy it as it is published there and do not change it. Always check the trial's own page for the latest.